Rising cancer diagnostics volumes increase demand for precision tissue sectioning equipment across pathology and research laboratories

The global Global Microtome market was valued at USD 392.5 Million in 2025 and is projected to reach USD 712.4 Million by 2035, registering a revenue CAGR of 6.1% during the forecast period, according to the latest analysis by Emergen Research Global LLP.

NEW YORK, June 23, 2026 - The global Global Microtome market was valued at USD 392.5 Million in 2025 and is expected to reach USD 712.4 Million by 2035, registering a revenue CAGR of 6.1% during the forecast period.

Demand for microtomes is increasing due to the growing need for accurate histopathology, cancer diagnostics, and biomedical research. Expanding laboratory testing volumes and rising investments in life science research are supporting adoption of advanced tissue sectioning instruments. According to the World Health Organization, cancer remains one of the leading causes of mortality worldwide, driving continued demand for pathology services and diagnostic infrastructure. Increasing use of precision medicine and biomarker-based testing is also contributing to the need for high-quality tissue preparation equipment.

KEY GROWTH DRIVERS

The market is benefiting from growth in diagnostic pathology, pharmaceutical research, and academic life science programs. Microtomes play a critical role in preparing thin tissue sections required for histological analysis, disease diagnosis, and drug development activities. Laboratories are increasingly adopting automated and semi-automated systems to improve workflow efficiency, reproducibility, and sample quality. Expanding healthcare infrastructure in emerging economies is creating additional demand for pathology equipment and laboratory instruments. For instance, in May 2024, Leica Biosystems, Germany, introduced enhancements to its pathology workflow solutions designed to improve laboratory productivity and tissue processing efficiency. Growing investments in cancer research, translational medicine, and diagnostic laboratory modernization continue to support equipment demand. These are some of the key factors driving revenue growth of the Global Microtome market.

MARKET RESTRAINTS

However, advanced microtome systems require substantial capital investment, which can limit adoption among smaller laboratories and healthcare facilities. Maintenance requirements, blade replacement costs, and operator training needs contribute to ongoing operational expenses. Regulatory requirements governing medical devices and laboratory equipment approvals can also increase product development timelines and compliance costs. In addition, shortages of trained pathology professionals in certain regions may affect the utilization of advanced tissue processing systems. These factors are expected to limit Global Microtome market growth to some extent over the forecast period.

SEGMENT HIGHLIGHTS

Based on product type, the rotary microtome segment accounted for the largest share of market revenue in 2025. Rotary microtomes are widely used in clinical pathology laboratories due to their reliability, precision, and suitability for routine histological applications. Their broad adoption across hospitals, diagnostic laboratories, and research institutions supports segment leadership.

The automated microtome segment is expected to register the fastest growth during the forecast period. Laboratories are increasingly investing in automation technologies to improve workflow consistency and reduce manual intervention. Automated systems also help laboratories manage growing sample volumes while maintaining quality standards.

Based on end use, hospitals and diagnostic laboratories represented the leading segment in 2025 due to rising demand for tissue-based diagnostics and cancer screening procedures. Pharmaceutical and biotechnology companies are expected to record strong growth as research activities and drug development programs continue to expand globally.

REGIONAL OUTLOOK

North America accounted for the largest share of the global market in 2025. The region benefits from advanced healthcare infrastructure, extensive pathology laboratory networks, and substantial investment in biomedical research. According to the National Cancer Institute, cancer research funding and clinical investigation activities continue to support demand for histopathology equipment across the United States. Major manufacturers such as Thermo Fisher Scientific and Danaher Corporation maintain a strong presence in the regional market.

Europe remains an important market due to established healthcare systems and a large concentration of academic and clinical research institutions. Germany, the United Kingdom, and France continue to invest in pathology modernization and diagnostic laboratory capacity. Companies such as Leica Biosystems maintain a strong market position through ongoing development of tissue preparation and pathology workflow technologies.

Asia Pacific is expected to register the fastest growth during the forecast period. Rising healthcare expenditure, expanding diagnostic infrastructure, and increasing cancer screening initiatives are supporting demand for pathology equipment across the region. China, India, Japan, and South Korea continue to invest in healthcare modernization and life science research capabilities. Government-supported healthcare expansion programs and growing laboratory networks are expected to drive market growth throughout the forecast period.

MEDIA CONTACT BLOCK

Contact: Debanjan Biswas
Company: Emergen Research Global LLP
Email: sales@emergenresearch.com
Website: www.emergenresearch.com

ABOUT EMERGEN RESEARCH GLOBAL LLP

Emergen Research Global LLP is a market research and consulting firm that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics and industries to help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Technology, Chemicals, Power, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market.

This release was published on openPR.